Table 3 Long-term prognosis outcomes on patients with stage II and stage III disease in the SEMS group and emergency group
|  | SEMS group (n = 28) | Emergency group (n = 65) | P |
|---|---|---|---|
Distant metastasis, no. (%) | 6 (21.4%) | 12 (18.5%)a | 0.740 |
 Liver | 1 (3.6%) | 7 (10.8%) | 0.427 |
 Others | 5 (17.9%) | 8 (12.3%) | 0.522 |
  Lungs | 2 (7.1%) | 4 (6.2%) |  |
  Peritoneum | 2 (7.1%) | 3 (4.6%) |  |
  Bone | 0 (0%) | 1 (1.5%) |  |
  Adrenal gland | 1 (3.6%) | 0 (0%) |  |
Local site relapse, no. (%) | 2 (7.1%) | 7 (10.8%) | 0.719 |
Death | 9 (32.1%) | 22 (33.8%) | 0.873 |